Form 8-K - Current report:
SEC Accession No. 0001558370-25-006838
Filing Date
2025-05-08
Accepted
2025-05-08 06:05:36
Documents
91
Period of Report
2024-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lqda-20241231x8k.htm   iXBRL 8-K 158144
2 EX-23.1 lqda-20241231xex23d1.htm EX-23.1 4801
3 EX-99.1 lqda-20241231xex99d1.htm   iXBRL EX-99.1 1427482
  Complete submission text file 0001558370-25-006838.txt   9811472

Data Files

Seq Description Document Type Size
4 EX-101.SCH lqda-20241231.xsd EX-101.SCH 82224
5 EX-101.CAL lqda-20241231_cal.xml EX-101.CAL 72395
6 EX-101.DEF lqda-20241231_def.xml EX-101.DEF 243734
7 EX-101.LAB lqda-20241231_lab.xml EX-101.LAB 673826
8 EX-101.PRE lqda-20241231_pre.xml EX-101.PRE 480859
94 EXTRACTED XBRL INSTANCE DOCUMENT lqda-20241231x8k_htm.xml XML 1981269
Mailing Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560
Business Address 419 DAVIS DRIVE, SUITE 100 MORRISVILLE NC 27560 919.328.4400
Liquidia Corp (Filer) CIK: 0001819576 (see all company filings)

EIN.: 851710962 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39724 | Film No.: 25923641
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)